Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iveric Bio Inc (NQ: ISEE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Iveric Bio Inc < Previous 1 2 3 4 Next > IVERIC bio Inc. (NASDAQ: ISEE) Records 52-Week High Thursday Morning July 06, 2023 Via Investor Brand Network Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 05, 2023 From IVERIC bio, Inc. Via Business Wire IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE June 14, 2023 From Kahn Swick & Foti, LLC Via Business Wire IVERIC bio Inc. (NASDAQ: ISEE) Making Surprising Moves in Monday Session June 05, 2023 Via Investor Brand Network Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 02, 2023 From IVERIC bio, Inc. Via Business Wire Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition? June 01, 2023 By David Willey, Benzinga Via TheNewswire.com Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 24, 2023 From IVERIC bio, Inc. Via Business Wire IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE May 02, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq – ISEE), Midwest Holding Inc. (Nasdaq – MDWT), Hoth Therapeutics, Inc. (Nasdaq – HOTH) May 01, 2023 From Brodsky & Smith LLC Via GlobeNewswire ISEE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Iveric bio, Inc. Is Fair to Shareholders May 01, 2023 From Halper Sadeh LLC Via Business Wire Astellas Enters Into Definitive Agreement to Acquire Iveric Bio April 30, 2023 From IVERIC Bio, Inc. Via Business Wire Iveric Bio Announces New Functional Vision Loss Reduction Data from Avacincaptad Pegol GATHER Trials Presented at ARVO Annual Meeting April 23, 2023 From IVERIC bio, Inc. Via Business Wire Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 04, 2023 From IVERIC bio, Inc. Via Business Wire Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 02, 2023 From IVERIC bio, Inc. Via Business Wire Iveric Bio Reports Fourth Quarter and Full Year 2022 Operational Highlights and Financial Results March 01, 2023 From IVERIC bio, Inc. Via Business Wire Iveric Bio Announces Vision Loss Reduction Data in Geographic Atrophy from Avacincaptad Pegol GATHER Trials March 01, 2023 From Iveric Bio Via Business Wire Iveric Bio to Present at the Cowen 43rd Annual Health Care Conference February 28, 2023 From IVERIC bio, Inc. Via Business Wire Iveric Bio to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on Wednesday, March 1, 2023 February 22, 2023 From IVERIC bio, Inc. Via Business Wire Iveric Bio Announces FDA Accepts New Drug Application and Grants Priority Review for Avacincaptad Pegol for the Treatment of Geographic Atrophy February 16, 2023 From IVERIC bio, Inc. Via Business Wire Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 02, 2023 From IVERIC bio, Inc. Via Business Wire Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) January 04, 2023 From IVERIC bio, Inc. Via Business Wire Iveric Bio Announces the Addition of Pravin U. Dugel, MD, to its Board of Directors January 03, 2023 From IVERIC bio, Inc. Via Business Wire Iveric Bio Announces Completion of Rolling NDA Submission to FDA for Avacincaptad Pegol for the Treatment of Geographic Atrophy December 20, 2022 From Iveric bio, Inc. Via Business Wire Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 02, 2022 From IVERIC bio, Inc. Via Business Wire Iveric Bio Announces Pricing of $300 Million Public Offering of Common Stock November 30, 2022 From IVERIC bio, Inc. Via Business Wire Iveric Bio Announces Proposed Offering of Common Stock November 30, 2022 From IVERIC bio, Inc. Via Business Wire Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation for Avacincaptad Pegol for Geographic Atrophy November 17, 2022 From IVERIC bio, Inc. Via Business Wire Iveric Bio to Present at Upcoming Investor Conferences November 04, 2022 From Iveric Bio Via Business Wire Iveric Bio Announces Submission of First Part of NDA for Rolling Review of Avacincaptad Pegol for the Treatment of Geographic Atrophy November 03, 2022 From IVERIC bio, Inc. Via Business Wire Iveric Bio Reports Third Quarter 2022 Operational Highlights and Financial Results November 03, 2022 From IVERIC bio, Inc. Via Business Wire < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
